Search
Spruce Biosciences Inc
SPRBAdd to Watchlist
52.920USD
-0.940-1.75%
Market hours 09/18, 13:02（ET）
145.68MMarket Cap
LossP/E TTM
Spruce Biosciences Inc (SPRB) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to Spruce Biosciences Inc in the past month.
Buy
3 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
147.875USD+168.06%
SPRB Analyst Recommendation Trends
In the current month, SPRB has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SPRB average Analyst price target in the last month is 147.875.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
3
3
3
2
2
2
2
1
5
5
4
3
3
2
2
2
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
7
5
5
4
4
4
SPRB Analyst Rating for Peer Comparison
Updated: Sep 17, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, SPRB EPS is projected to reach -5.595 in FY2026Q3, following reported EPS of -6.676 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-7.99
-8.82
-5.80
-5.59
-5.73
Actual
-11.28
-8.94
-6.68
--
--
Surprise
-41.32%
-1.40%
-15.07%
--
--
FAQs
What is Spruce Biosciences Inc's price target?
Analysts forecast that Spruce Biosciences Inc's price target is USD 147.88, with the highest forecast at USD 230.00 and the lowest forecast at USD 104.00.
How have Spruce Biosciences IncSPRB's recent earnings per share performed?
The market expectation was USD -6.68, while Spruce Biosciences IncSPRB's earnings per share (EPS) for the previous quarter was USD -8.94. EPS for the next quarter is expected at USD -5.59.
What is the analyst rating for Spruce Biosciences Inc?
Based on the ratings of Spruce Biosciences Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.